Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase

[1]  S. Treweek,et al.  Strategies to improve recruitment to randomised trials. , 2018, The Cochrane database of systematic reviews.

[2]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[3]  P. Hutchinson,et al.  The British Neurosurgical Trainee Research Collaborative: Five years on , 2017, Acta Neurochirurgica.

[4]  A. Jamjoom,et al.  Randomized controlled trials in neurosurgery: an observational analysis of trial discontinuation and publication outcome. , 2017, Journal of neurosurgery.

[5]  P. Hutchinson,et al.  Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy , 2017, Journal of Neuroinflammation.

[6]  M. Rogers,et al.  Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study , 2017, British Medical Journal.

[7]  C. Gamble,et al.  Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies , 2017, BMJ Open.

[8]  Feiran Sun,et al.  Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone , 2017, British journal of neurosurgery.

[9]  L. Marshman,et al.  Long-term survival after chronic subdural haematoma , 2016, Journal of Clinical Neuroscience.

[10]  P. Tugwell,et al.  CONSORT 2010 statement: extension to randomised pilot and feasibility trials , 2016, British Medical Journal.

[11]  T. Santarius,et al.  Core Outcomes and Common Data Elements in Chronic Subdural Hematoma: A Systematic Review of the Literature Focusing on Reported Outcomes , 2016, Journal of neurotrauma.

[12]  E. Matteson,et al.  Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. , 2016, JAMA.

[13]  S. Cottin,et al.  A Pilot Placebo Controlled Randomized Trial of Dexamethasone for Chronic Subdural Hematoma , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[14]  D. Kondziolka,et al.  Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered? , 2016, Journal of neurosurgery.

[15]  F. Barker.  Editorial: Randomized clinical trials and neurosurgery. , 2016, Journal of neurosurgery.

[16]  A. K. Thotakura,et al.  Nonsurgical Treatment of Chronic Subdural Hematoma with Steroids. , 2015, World neurosurgery.

[17]  M. Melbye,et al.  Recurrence of Subdural Haematoma in a Population-Based Cohort – Risks and Predictive Factors , 2015, PloS one.

[18]  W. Poon,et al.  Steroid for chronic subdural hematoma? A prospective phase IIB pilot randomized controlled trial on the use of dexamethasone with surgical drainage for the reduction of recurrence with reoperation , 2015, Chinese Neurosurgical Journal.

[19]  A. Brodbelt,et al.  Glioblastoma in England: 2007-2011. , 2015, European journal of cancer.

[20]  J. Wardle,et al.  Sleep and nighttime energy consumption in early childhood: a population‐based cohort study , 2015, Pediatric obesity.

[21]  J. Walters,et al.  Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. , 2014, The Cochrane database of systematic reviews.

[22]  T. Santarius,et al.  Chronic subdural haematoma: modern management and emerging therapies , 2014, Nature Reviews Neurology.

[23]  W. Hitzl,et al.  The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial , 2014, Trials.

[24]  G. Rait,et al.  Strategies to improve retention in randomised trials , 2013, The Cochrane database of systematic reviews.

[25]  M. Aries,et al.  Cerebral perfusion changes in chronic subdural hematoma. , 2013, Journal of neurotrauma.

[26]  Gillian E. Caughey,et al.  Comorbid Diabetes and COPD , 2013, Diabetes Care.

[27]  J. Piercy,et al.  Community consultation in emergency neurotrauma research: results from a pre-protocol survey , 2013, Acta Neurochirurgica.

[28]  C. Dirven,et al.  The role of corticosteroids in the management of chronic subdural hematoma: a systematic review , 2012, European journal of neurology.

[29]  Geoff Watts,et al.  Why the exclusion of older people from clinical research must stop , 2012, BMJ : British Medical Journal.

[30]  Hester F. Lingsma,et al.  Clinical Factors Associated With Outcome in Chronic Subdural Hematoma: A Retrospective Cohort Study of Patients on Preoperative Corticosteroid Therapy , 2012, Neurosurgery.

[31]  L. Trinquart,et al.  Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs , 2012, PloS one.

[32]  J. Switzer,et al.  Simplified Modified Rankin Scale Questionnaire: Reproducibility Over the Telephone and Validation With Quality of Life , 2011, Stroke.

[33]  T. Santarius,et al.  Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial , 2009, The Lancet.

[34]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[35]  Jae-Min Kim,et al.  Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. , 2009, Surgical neurology.

[36]  F. Erol,et al.  The effectiveness of simple drainage technique in improvement of cerebral blood flow in patients with chronic subdural hemorrhage. , 2007, Turkish neurosurgery.

[37]  S. Vondracek,et al.  Is There an Optimal Corticosteroid Regimen for the Management of an Acute Exacerbation of Chronic Obstructive Pulmonary Disease? , 2006, Pharmacotherapy.

[38]  K. Ogasawara,et al.  Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma , 2006, Neurosurgical Review.

[39]  M. Mcmurdo,et al.  Including older people in clinical research , 2005, BMJ : British Medical Journal.

[40]  H. Cohen,et al.  Never too old? Age should not be a barrier to enrollment in cancer clinical trials. , 2005, The oncologist.

[41]  W. Poon,et al.  Non-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasone , 2005, British journal of neurosurgery.

[42]  P. Sandercock,et al.  Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial , 2004, The Lancet.

[43]  Kenneth F Schulz,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Exclusions before Randomisation Exclusions after Randomisation Sample Size Slippages in Randomised Trials: Exclusions and the Lost and Wayward , 2022 .

[44]  S. Inao,et al.  Relation between brain displacement and local cerebral blood flow in patients with chronic subdural haematoma , 2001, Journal of neurology, neurosurgery, and psychiatry.

[45]  M. Y. Lee,et al.  The Application of Transcranial Doppler Sonography in Patients with Chronic Subdural Haematoma , 1999, Acta Neurochirurgica.

[46]  B. Rosen,et al.  Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.

[47]  N. Black.  CONSORT , 1996, The Lancet.

[48]  W. van Putten,et al.  Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors , 1994, Neurology.

[49]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[50]  M. B. Bender,et al.  Nonsurgical treatment of subdural hematomas. , 1974, Archives of neurology.

[51]  The Lancet Psychiatry.  Five years. , 2016, The lancet. Psychiatry.

[52]  A. Preiss,et al.  Impact of corticosteroid use on diabetes complications , 2013 .

[53]  W. Stummer,et al.  Cerebral perfusion changes in chronic subdural hematoma. , 2013, Journal of neurotrauma.

[54]  Gillian,et al.  Comorbid Diabetes and COPD Impact of corticosteroid use on diabetes complications , 2013 .

[55]  M. Stanišić,et al.  Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study , 2011, Acta Neurochirurgica.

[56]  P. Delgado-López,et al.  Dexamethasone treatment in chronic subdural haematoma. , 2009, Neurocirugia.

[57]  J. Manson,et al.  Prospective Study of , 2007 .

[58]  J. Haselgrove,et al.  Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging , 2005, Acta Neurochirurgica.

[59]  H. Herrmann,et al.  The influence of dexamethasone on the blood-brain-barrier and water content in experimental brain oedema , 2005, Acta Neurochirurgica.

[60]  J. Swieten.  Interobserver Agreement for the Assessment of Handicap in Stroke Patients , 2005 .

[61]  R. Delfini,et al.  Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. , 2004, Journal of neurosurgery.

[62]  S. Hampson.  Randomised, placebo-controlled trial , 2002 .

[63]  F. Jensen,et al.  Differences in Blood-Tumour-Barrier Leakage of Human Intracranial Tumours: Quantitative Monitoring of Vasogenic Oedema and its Response to Glucocorticoid Treatment , 1998, Acta Neurochirurgica.

[64]  D. Long,et al.  The Clinical Effects of a Synthetic Gluco-Corticoid used for Brain Edema in the Practice of Neurosurgery , 1972 .

[65]  F. Barker.  Randomized clinical trials and neurosurgery , 2022 .